StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
440
This month
1
This week
1
This year
26
Publishing Date
2024 - 02 - 12
3
2023 - 11 - 01
3
2023 - 09 - 05
3
2023 - 07 - 11
4
2023 - 04 - 27
3
2023 - 04 - 17
4
2023 - 03 - 08
3
2022 - 11 - 17
5
2022 - 11 - 10
3
2022 - 11 - 07
4
2022 - 09 - 15
3
2022 - 06 - 06
3
2022 - 05 - 23
2
2022 - 05 - 09
4
2022 - 05 - 02
7
2022 - 04 - 28
2
2022 - 04 - 27
3
2022 - 04 - 26
2
2022 - 04 - 14
3
2022 - 04 - 08
2
2022 - 04 - 06
2
2022 - 03 - 31
2
2022 - 03 - 14
2
2022 - 03 - 03
3
2022 - 02 - 16
2
2022 - 01 - 24
3
2022 - 01 - 18
2
2022 - 01 - 13
2
2022 - 01 - 11
3
2022 - 01 - 10
4
2022 - 01 - 06
2
2021 - 12 - 22
3
2021 - 12 - 07
2
2021 - 11 - 30
5
2021 - 11 - 17
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 11 - 08
3
2021 - 11 - 05
2
2021 - 11 - 02
2
2021 - 10 - 07
2
2021 - 10 - 01
4
2021 - 09 - 29
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 08 - 23
2
2021 - 07 - 28
2
2021 - 07 - 27
3
2021 - 07 - 22
2
2021 - 07 - 14
3
2021 - 06 - 09
2
2021 - 05 - 28
3
2021 - 05 - 26
2
2021 - 04 - 27
3
2021 - 04 - 20
3
2021 - 04 - 14
2
2021 - 04 - 07
2
2021 - 03 - 08
2
2021 - 01 - 25
2
2020 - 12 - 17
2
Sector
Commercial services
2
Communications
1
Consumer non-durables
5
Electronic technology
1
Finance
2
Health services
18
Health technology
343
Manufacturing
22
Mining, quarrying, and oil and gas extraction
1
N/a
2
Non-energy minerals
1
Process industries
2
Professional, scientific, and technical services
6
Retail trade
1
Technology services
11
Wholesale trade
3
Tags
Acquisition
736
Agreement
909
America
658
Application
1355
Approval
1345
Business
629
Cancer
1839
Collaboration
682
Conference
2316
Contract
832
Corporation
826
Covid
767
Covid-19
581
Designation
906
Disease
1188
Drug
1436
Energy
1428
Europe
736
Events
558
Fda
2709
Financial
2027
Financial results
964
For
547
Global
1745
Group
652
Growing
626
Growth
2826
Health
887
License
671
Management
599
Market
3375
Meeting
985
N/a
45948
Order
627
Partnership
553
Patent
818
Pharm-country
597
Pharmaceuticals
664
Phase 2
720
Platform
656
Positive
1225
Potential
632
Presentation
597
Program
754
Report
1744
Research
2556
Results
4573
Services
663
Solutions
711
Study
842
System
771
Technology
1171
Test
715
Therapeutics
1791
Therapy
1313
Treatment
3924
Trial
2264
Update
644
Vaccine
597
Year
1844
Entities
Abbvie inc.
3
Abvc biopharma inc
3
Adicet bio, inc.
3
Agilent technologies, inc.
7
Allogene therapeutics, inc.
3
Amgen inc.
4
An2 therapeutics, inc.
3
Anixa biosciences, inc.
5
Aslan pharmaceuticals limited
3
Atara biotherapeutics, inc.
5
Avinger, inc.
4
Better therapeutics inc
8
Biotelemetry, inc.
5
Biotricity inc
6
Bridgebio pharma, inc.
3
Bristol-myers squibb company
6
Caredx, inc.
9
Coherus biosciences, inc.
5
Corvus pharmaceuticals, inc.
3
Cymabay therapeutics inc.
6
Cytokinetics, incorporated
3
Denali therapeutics inc.
3
Eiger biopharmaceuticals, inc.
7
Eli lilly and company
10
Exelixis, inc.
6
Geron corporation
5
Gilead sciences, inc.
11
Grifols, s.a.
3
Guardant health, inc.
14
Humanigen, inc.
5
Ideaya biosciences, inc.
8
Illumina, inc.
6
Incyte corporation
3
Invitae corporation
3
Jaguar health, inc.
9
Johnson & johnson
4
Kering
5
Mereo biopharma group plc
3
Mirum pharmaceuticals, inc.
11
Nektar therapeutics
8
Nurix therapeutics, inc.
4
Omnicell, inc.
6
Personalis, inc.
8
Protagonist therapeutics, inc.
4
Pulse biosciences, inc
16
Regeneron pharmaceuticals, inc.
4
Sanofi
14
Shockwave medical, inc.
4
Soleno therapeutics, inc.
3
Summit therapeutics inc.
8
Sutro biopharma, inc.
5
Takeda pharmaceutical company limited
5
Twist bioscience corporation
11
Ultragenyx pharmaceutical inc.
9
Vaxcyte, inc.
4
Veeva systems inc.
3
Veracyte, inc.
9
Vincera pharma inc
3
Vir biotechnology, inc.
3
Vistagen therapeutics, inc.
7
Symbols
A
7
ABBV
3
ABVC
3
ACET
3
ALLO
3
AMGN
4
ANIX
5
ANTX
3
ASLN
3
ATRA
5
AVGR
4
BBIO
3
BEAT
5
BMY
6
BTCY
6
BTTX
8
CBAY
6
CDNA
9
CHRS
5
CRVS
3
CYTK
3
DNLI
3
EIGR
7
EXEL
6
GERN
5
GH
14
GILD
11
GRFS
3
HGEN
5
IDYA
8
ILMN
6
INCY
3
JAGX
9
JNJ
4
LLY
10
MIRM
11
MREO
3
NKTR
8
NRIX
4
NVTA
3
OMCL
6
PCVX
4
PLSE
16
PPRUF
5
PPRUY
5
PSNL
8
PTGX
4
RARE
9
REGN
4
SLNO
3
SMMT
8
SNY
14
SNYNF
13
STRO
5
SWAV
4
TAK
5
TWST
11
VCYT
9
VEEV
3
VTGN
7
Exchanges
Amex
2
Nasdaq
411
Nyse
53
Crawled Date
2024 - 02 - 12
3
2023 - 11 - 01
3
2023 - 09 - 05
3
2023 - 07 - 11
4
2023 - 04 - 27
3
2023 - 04 - 17
4
2023 - 03 - 08
3
2022 - 11 - 17
5
2022 - 11 - 10
3
2022 - 11 - 07
4
2022 - 09 - 15
3
2022 - 06 - 06
3
2022 - 05 - 09
4
2022 - 05 - 02
7
2022 - 04 - 28
2
2022 - 04 - 27
3
2022 - 04 - 26
2
2022 - 04 - 22
2
2022 - 04 - 14
3
2022 - 04 - 08
2
2022 - 04 - 06
2
2022 - 03 - 31
2
2022 - 03 - 14
2
2022 - 03 - 03
3
2022 - 02 - 16
2
2022 - 01 - 24
3
2022 - 01 - 19
2
2022 - 01 - 13
2
2022 - 01 - 11
3
2022 - 01 - 10
4
2022 - 01 - 06
2
2021 - 12 - 22
3
2021 - 12 - 07
2
2021 - 11 - 30
5
2021 - 11 - 17
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 11 - 08
3
2021 - 11 - 05
2
2021 - 11 - 02
2
2021 - 10 - 07
2
2021 - 10 - 01
4
2021 - 09 - 29
2
2021 - 09 - 20
2
2021 - 09 - 09
3
2021 - 08 - 23
2
2021 - 07 - 28
2
2021 - 07 - 27
3
2021 - 07 - 22
2
2021 - 07 - 14
3
2021 - 06 - 09
2
2021 - 05 - 28
3
2021 - 05 - 26
2
2021 - 04 - 27
3
2021 - 04 - 20
3
2021 - 04 - 14
2
2021 - 04 - 07
2
2021 - 03 - 08
2
2021 - 01 - 25
2
2020 - 12 - 17
2
Crawled Time
00:00
4
01:00
3
06:00
1
07:00
1
09:00
2
11:00
5
12:00
26
12:15
2
12:20
11
12:30
3
13:00
50
13:01
1
13:15
5
13:20
12
13:30
7
14:00
71
14:15
6
14:20
6
14:30
12
15:00
42
15:15
4
15:20
8
15:30
6
16:00
14
16:03
1
17:00
17
18:00
19
18:01
1
19:00
15
20:00
10
20:01
1
21:00
22
22:00
25
22:01
2
22:02
1
23:00
24
Source
www.biospace.com
440
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
tags :
Biotech-bay
save search
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Published:
2024-04-15
(Crawled : 14:00)
- biospace.com/
A
|
$134.55
-1.65%
-0.85%
2.1M
|
Health Technology
|
-2.79%
|
O:
1.12%
H:
0.66%
C:
-1.47%
certification
assay
for
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
Published:
2024-03-27
(Crawled : 23:00)
- biospace.com/
ILMN
|
$118.305
0.52%
0.52%
1.9M
|
Health Technology
|
-12.04%
|
O:
1.28%
H:
2.34%
C:
2.34%
galleri
association
cancer
research
meeting
platform
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
Published:
2024-03-26
(Crawled : 17:00)
- biospace.com/
PSNL
|
$1.2
-3.23%
-3.33%
360K
|
Health Technology
|
-13.89%
|
O:
4.17%
H:
2.0%
C:
-4.67%
personal
test
cancer
publication
treatment
response
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published:
2024-03-18
(Crawled : 14:00)
- biospace.com/
SCLX
|
$1.17
0.86%
0.85%
470K
|
|
-15.33%
|
O:
-0.73%
H:
3.31%
C:
0.74%
elyxyb
drug
patent
company
health
approval
review
canada
submission
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Published:
2024-03-14
(Crawled : 13:30)
- biospace.com/
NBY
|
$0.0829
4.28%
0.0%
13M
|
Health Technology
|
-43.86%
|
O:
5.93%
H:
0.0%
C:
-10.2%
business
year
pharmaceuticals
financial
agreement
results
QT Imaging’s Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy
Published:
2024-03-14
(Crawled : 13:30)
- biospace.com/
GIA
|
$1.08
237.96%
1.4K
|
|
Email alert
Add to watchlist
breast
cancer
response
study
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
MIRM
|
$23.87
-0.58%
-0.59%
330K
|
Health Technology
|
-12.63%
|
O:
1.49%
H:
2.98%
C:
-0.43%
fda
pruritus
approval
treatment
livmarli
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Published:
2024-03-13
(Crawled : 23:00)
- biospace.com/
GH
|
$16.4
1.49%
1.46%
1.5M
|
Health Services
|
-13.3%
|
O:
-0.75%
H:
4.38%
C:
2.7%
test
health
cancer
study
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
Published:
2024-03-07
(Crawled : 15:30)
- biospace.com/
BEAT
|
$2.14
18.89%
15.89%
270K
|
Health Technology
|
11.11%
|
O:
3.7%
H:
39.55%
C:
22.02%
cardiac
technology
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Published:
2024-03-05
(Crawled : 15:30)
- biospace.com/
TWST
|
$28.54
-0.25%
-0.25%
840K
|
Health Technology
|
-25.18%
|
O:
-1.15%
H:
0.9%
C:
-2.67%
precision
bioscience
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies
Published:
2024-03-04
(Crawled : 15:00)
- biospace.com/
BTTX
|
$0.0093
-65.02%
250K
|
|
-94.92%
|
O:
1.36%
H:
5.86%
C:
4.35%
day
conference
international
trial
therapeutics
advanced
Biotricity Receives Health Canada Clearance for Biotres
Published:
2024-02-29
(Crawled : 17:00)
- biospace.com/
BTCY
|
$1.25
4.17%
4.0%
87K
|
Manufacturing
|
30.41%
|
O:
1.09%
H:
10.73%
C:
7.5%
health
clearance
canada
Atara Biotherapeutics Receives FDA Clearance of IND Application in Lupus Nephritis for ATA3219, an Allogeneic CAR T Therapy
Published:
2024-02-29
(Crawled : 15:00)
- biospace.com/
ATRA
|
$0.7201
5.65%
5.35%
830K
|
Health Technology
|
-10.37%
|
O:
10.45%
H:
11.61%
C:
-7.38%
ata3219
fda
lupus
clearance
application
therapy
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease
Published:
2024-02-20
(Crawled : 15:30)
- biospace.com/
BTTX
|
$0.0093
-65.02%
250K
|
|
-95.73%
|
O:
7.55%
H:
2.13%
C:
-27.83%
fda
device
liver
disease
designation
therapeutics
advanced
platform
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
Published:
2024-02-12
(Crawled : 14:30)
- biospace.com/
SGMO
|
$0.513
-5.35%
-5.65%
1.2M
|
Health Technology
|
-5.64%
|
O:
8.46%
H:
35.96%
C:
29.21%
st-920
fda
disease
approval
prime
ema
therapeutics
potential
Jaguar Health Announces Submission of Orphan Drug Designation Application to the FDA for Crofelemer for Cholera-Related Diarrhea
Published:
2024-02-12
(Crawled : 14:30)
- biospace.com/
JAGX
|
$0.1637
-8.19%
-8.92%
130M
|
Health Technology
|
113.02%
|
O:
6.09%
H:
7.88%
C:
0.68%
fda
drug
diarrhea
health
designation
application
crofelemer
submission
CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar for the Treatment of Primary Biliary Cholangitis
Published:
2024-02-12
(Crawled : 14:30)
- biospace.com/
CBAY
|
$32.48
0.03%
8.4M
|
Health Technology
|
30.09%
|
O:
27.92%
H:
0.97%
C:
0.88%
fda
review
treatment
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
Published:
2024-02-06
(Crawled : 14:00)
- biospace.com/
TWST
|
$28.54
-0.25%
-0.25%
840K
|
Health Technology
|
-21.42%
|
O:
-0.33%
H:
3.06%
C:
1.87%
bioscience
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Published:
2024-01-30
(Crawled : 15:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-14.87%
|
O:
-0.34%
H:
0.13%
C:
-0.23%
yescarta
fda
t-cell
change
approval
therapy
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
Published:
2024-01-30
(Crawled : 15:00)
- biospace.com/
OSA
|
$0.5
-4.56%
-4.78%
59K
|
n/a
|
-36.11%
|
O:
-1.22%
H:
3.21%
C:
-7.41%
fda
review
prosomnus
submission
← Previous
1
2
3
4
5
6
7
8
9
…
21
22
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.